MCL1 and acute myeloid leukemia: HHT was reported to induce the decreased synthesis of short-life proteins that are related to proliferation and apoptosis (e.g., c-Myc, Mcl-1, cyclin D1, β-catenin, Bcl-Abl, etc.), and has been used in clinical trials of AML for decades [42].